Gynecological Oncology — Medicare Part B billing by state
21 physician groups whose primary specialty is Gynecological Oncology billed $3.8M to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| New Mexico | $1.6M | $1.6M | 2 | $812K | 94,753 | 3,555 | 47,376 |
| Florida | $965K | $999K | 3 | $333K | 54,478 | 3,430 | 18,159 |
| Tennessee | $202K | $186K | 1 | $186K | 9,578 | 1,127 | 9,578 |
| California | $197K | $210K | 2 | $105K | 2,206 | 1,780 | 1,103 |
| Nevada | $161K | $153K | 2 | $76K | 1,878 | 1,429 | 939 |
| Alabama | $145K | $143K | 1 | $143K | 12,012 | 9,920 | 12,012 |
| New Jersey | $104K | $110K | 1 | $110K | 1,582 | 1,279 | 1,582 |
| New York | $92K | $109K | 3 | $36K | 1,003 | 743 | 334 |
| North Carolina | $85K | $80K | 1 | $80K | 2,513 | 860 | 2,513 |
| Texas | $57K | $55K | 1 | $55K | 971 | 511 | 971 |
| Missouri | $49K | $47K | 1 | $47K | 599 | 449 | 599 |
| Washington | $24K | $30K | 1 | $30K | 280 | 118 | 280 |
| Louisiana | $19K | $17K | 1 | $17K | 218 | 185 | 218 |
| Alaska | $10K | $13K | 1 | $13K | 137 | 83 | 137 |
| Georgia | $7K | $7K | 1 | $7K | 111 | 74 | 111 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
8 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J9271 · Injection, pembrolizumab, 1 mg | $987K | 41,200 | NMFLTNCANV |
| J9035 · Injection, bevacizumab, 10 mg | $433K | 7,553 | NMFLTNCANV |
| Q5129 · Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | $180K | 3,970 | NMFLTNCANV |
| J0185 · Injection, aprepitant, 1 mg top by services | $22K | 16,640 | NMFLTNCANV |
| J9267 · Injection, paclitaxel, 1 mg top by services | $4K | 52,406 | NMFLTNCANV |
| J1453 · Injection, fosaprepitant, 1 mg top by services | $678 | 6,150 | NMFLTNCANV |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | $642 | 7,237 | NMFLTNCANV |